IMIPRAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Imipramine patents expire, and what generic alternatives are available?
Imipramine is a drug marketed by Novartis, Chartwell, Leading, Lederle, Oxford Pharms, Par Pharm, Roxane, Sandoz, Specgx Llc, Strides Pharma Intl, Sun Pharm Industries, Teva, Usl Pharma, Vangard, Watson Labs, West Ward, Hikma, Lupin Ltd, and Rising. and is included in thirty-nine NDAs.
The generic ingredient in IMIPRAMINE is imipramine pamoate. There are thirty-four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the imipramine pamoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Imipramine
A generic version of IMIPRAMINE was approved as imipramine pamoate by HIKMA on April 16th, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for IMIPRAMINE?
- What are the global sales for IMIPRAMINE?
- What is Average Wholesale Price for IMIPRAMINE?
Summary for IMIPRAMINE
| US Patents: | 0 |
| Applicants: | 19 |
| NDAs: | 39 |
| Drug Prices: | Drug price information for IMIPRAMINE |
| DailyMed Link: | IMIPRAMINE at DailyMed |
US Patents and Regulatory Information for IMIPRAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 085875-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Sun Pharm Industries | IMIPRAMINE HYDROCHLORIDE | imipramine hydrochloride | TABLET;ORAL | 081050-001 | Jun 5, 1990 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Hikma | IMIPRAMINE PAMOATE | imipramine pamoate | CAPSULE;ORAL | 091099-002 | Apr 16, 2010 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
